Sensitivity analyses results for dapagliflozin arm versus acarbose arm (results per patient).
dataset
posted on 2016-11-02, 17:31 authored by Shuyan Gu, Yiming Mu, Suodi Zhai, Yuhang Zeng, Xuemei Zhen, Hengjin DongSensitivity analyses results for dapagliflozin arm versus acarbose arm (results per patient).
History
Usage metrics
Keywords
healthcare payer perspectivesensitivity analysesChina Objectivetreatment-naive patientsSensitivity analysesType 2 Diabetes40 yearsdisease burdentreatment comparisondapagliflozinhospital surveysSystematic literature reviewscost-effectivenesscomparator therapiestype 2 diabetes mellitusQALY gainmortality eventsCardiff Diabetes ModelT 2DMmodel-required patient profilesConclusion Dapagliflozinalternative medicationChinese T 2DM patientsacarbosedisease progressionmonotherapy
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC